The Hidden Crisis Challenging the Future of Regenerative Medicine

Publisher name

Pharmaceutical Technology

The commentary discusses systemic pressures facing the regenerative medicine sector beyond scientific development, including fragile business models, reimbursement uncertainty, and limited manufacturing scalability. It argues that without coordinated policy, financing, and infrastructure solutions, many advanced therapies may struggle to transition from clinical promise to sustainable real-world availability.

👉 Read the full article: The hidden crisis in regenerative medicine

Disclaimer

Images are illustrative only. This content does not constitute medical advice. SSCTR is not responsible for clinical or regulatory decisions. The content is provided for informational and educational purposes only.